Celltheon has been developing Cell Engineering technologies since 2012. Celltheon has patents, granted and pending, for its CHOK-1 derived SUPERCELL™ cell line and its unique DNA and RNA vector elements that are applicable for recombinant biotherapeutics such as Mabs, Difficult to Express Proteins (... Read more
Org chart
Collapse
Board & advisors
Teams
Offices
Vaxcyte
5 followers
Mineralys Therapeutics
3 followers
Immunome
2 followers
CG Oncology
2 followers
ZBiotics
2 followers
Kyverna Therapeutics
7 followers
Cogent Biosciences
1 follower
PMV Pharmaceuticals
1 follower
Paratus Sciences
1 follower
Thermo Fisher Scientific
284 followers
Genentech
226 followers
Gilead Sciences
213 followers